Applied Therapeutics ( APLT ) Upgraded to Buy: Here's Why

Zacks Commentary
2025.11.27 19:32

Applied Therapeutics (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).